Literature DB >> 16699941

[Requirements of a regional medical service for drug addicted patients].

Martin Schmidt1, Michael V Cranach, Stefan Egger.   

Abstract

Modern services for persons with disorders resulting from psychoactive drug abuse must conform to the complexity of their needs. Low threshold access, standards for the prescription of opiates, out-patient, in-patient and day-hospital detoxification, rehabilitation and abstinence oriented strategies are fundamental prerequisites. The quality of services for drug dependent patients is defined by the percentage finding access to the service, the percentage of those continuing in the service, the easy and rapid transition between the different elements of the service, the degree of abstinence, decriminalization, physical comorbidity and mortality. Finally the cost of treated and untreated drug dependence should be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699941     DOI: 10.1007/s10354-005-0256-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  13 in total

1.  A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.

Authors:  M Gossop; J Strang
Journal:  Br J Psychiatry       Date:  1991-05       Impact factor: 9.319

2.  A controlled trial of buprenorphine treatment for opioid dependence.

Authors:  R E Johnson; J H Jaffe; P J Fudala
Journal:  JAMA       Date:  1992-05-27       Impact factor: 56.272

3.  Clinical significance of the sparteine/debrisoquine oxidation polymorphism.

Authors:  K Brøsen; L F Gram
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  [Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept].

Authors:  K Rohrmeister; G Bernert; M Langer; G Fischer; M Weninger; A Pollak
Journal:  Z Geburtshilfe Neonatol       Date:  2001 Nov-Dec       Impact factor: 0.685

5.  Clinical pharmacology of buprenorphine: ceiling effects at high doses.

Authors:  S L Walsh; K L Preston; M L Stitzer; E J Cone; G E Bigelow
Journal:  Clin Pharmacol Ther       Date:  1994-05       Impact factor: 6.875

6.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Authors:  R E Johnson; M A Chutuape; E C Strain; S L Walsh; M L Stitzer; G E Bigelow
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

7.  Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment.

Authors:  C B Eap; M Bourquin; J Martin; J Spagnoli; S Livoti; K Powell; P Baumann; J Déglon
Journal:  Drug Alcohol Depend       Date:  2000-12-22       Impact factor: 4.492

8.  Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics.

Authors:  C B Eap; T Finkbeiner; M Gastpar; N Scherbaum; K Powell; P Baumann
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

9.  Buprenorphine in pregnant opioid-dependent women: first results of a prospective study.

Authors:  I Lacroix; A Berrebi; C Chaumerliac; M Lapeyre-Mestre; J L Montastruc; C Damase-Michel
Journal:  Addiction       Date:  2004-02       Impact factor: 6.526

10.  Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes.

Authors:  M Gossop; P Griffiths; B Bradley; J Strang
Journal:  Br J Psychiatry       Date:  1989-03       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.